Supplementary Material for: Real-world effectiveness of piperacillin/tazobactam with and without linezolid for spontaneous bacterial peritonitis by Quickert S. (12023954)

“…Treatment failure, defined as the need to escalate antibiotic therapy due to in vitro resistance, lack of neutrophil decrease in ascitic fluid, or clinical decision, and 30-day survival were retrospectively assessed. …”

Supplementary Material for: Real-world effectiveness of piperacillin/tazobactam with and without linezolid for spontaneous bacterial peritonitis by Quickert S. (12023954)

“…Treatment failure, defined as the need to escalate antibiotic therapy due to in vitro resistance, lack of neutrophil decrease in ascitic fluid, or clinical decision, and 30-day survival were retrospectively assessed. …”

Defective spermatogenesis and altered expression of CREB in CF mice testis. by Wen Ming Xu (221689)

“…Bar  = 20 µm (upper panel) or 50 µm (lower panel). (<b>E</b>) Statistic shows slight decrease in tubular diameter is observed in −/− testes. …”

Ex vivo fitness, CTL escape phenotype and sequence evolution of <i>gag</i> p24 CTL escape mutants. by Ryan M. Troyer (265934)

“…The fold escape conferred by each mutation is displayed here as the ratio of effective peptide concentration (EC₅₀) required to elicit 50% of maximal ELISpot signal relative to the pre-escape peptide <a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1000365#ppat.1000365-Cao2" target="_blank">[54]</a>. …”

Prognostic Value of CD109+ Circulating Endothelial Cells in Recurrent Glioblastomas Treated with Bevacizumab and Irinotecan by Lucia Cuppini (457787)

“…<div><p>Background</p><p>Recent data suggest that circulating endothelial and progenitor cells (CECs and CEPs, respectively) may have predictive potential in cancer patients treated with bevacizumab, the antibody recognizing vascular endothelial growth factor (VEGF). Here we report on CECs and CEPs investigated in 68 patients affected by recurrent glioblastoma (rGBM) treated with bevacizumab and irinotecan and two Independent Datasets of rGBM patients respectively treated with bevacizumab alone (n=32, independent dataset A: IDA) and classical antiblastic chemotherapy (n=14, independent dataset B: IDB).…”

Altered Heart Rates Precede Death. by David S. Auerbach (470466)

“…<p>A. DS mice exhibit significant QT prolongation (50 - 90%). …”

Image_1_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…In 2019, a decrease in the incidence rate of LRI was observed at the global level up to the 25–29 age group, then the incidence rates increased with age. …”

Table_3_Global burden of lower respiratory infections during the last three decades.DOC by Saeid Safiri (3713035)

“…In 2019, a decrease in the incidence rate of LRI was observed at the global level up to the 25–29 age group, then the incidence rates increased with age. …”

Image_5_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…In 2019, a decrease in the incidence rate of LRI was observed at the global level up to the 25–29 age group, then the incidence rates increased with age. …”

Presentation_2_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…In 2019, a decrease in the incidence rate of LRI was observed at the global level up to the 25–29 age group, then the incidence rates increased with age. …”

Image_11_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…In 2019, a decrease in the incidence rate of LRI was observed at the global level up to the 25–29 age group, then the incidence rates increased with age. …”

Image_14_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…In 2019, a decrease in the incidence rate of LRI was observed at the global level up to the 25–29 age group, then the incidence rates increased with age. …”

Image_9_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…In 2019, a decrease in the incidence rate of LRI was observed at the global level up to the 25–29 age group, then the incidence rates increased with age. …”

Table_2_Global burden of lower respiratory infections during the last three decades.DOC by Saeid Safiri (3713035)

“…In 2019, a decrease in the incidence rate of LRI was observed at the global level up to the 25–29 age group, then the incidence rates increased with age. …”

Image_8_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…In 2019, a decrease in the incidence rate of LRI was observed at the global level up to the 25–29 age group, then the incidence rates increased with age. …”

Table_1_Global burden of lower respiratory infections during the last three decades.DOCX by Saeid Safiri (3713035)

“…In 2019, a decrease in the incidence rate of LRI was observed at the global level up to the 25–29 age group, then the incidence rates increased with age. …”

Image_15_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…In 2019, a decrease in the incidence rate of LRI was observed at the global level up to the 25–29 age group, then the incidence rates increased with age. …”

Image_3_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…In 2019, a decrease in the incidence rate of LRI was observed at the global level up to the 25–29 age group, then the incidence rates increased with age. …”

Presentation_1_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…In 2019, a decrease in the incidence rate of LRI was observed at the global level up to the 25–29 age group, then the incidence rates increased with age. …”

Image_12_Global burden of lower respiratory infections during the last three decades.PDF by Saeid Safiri (3713035)

“…In 2019, a decrease in the incidence rate of LRI was observed at the global level up to the 25–29 age group, then the incidence rates increased with age. …”